Header Logo

Connection

Michelle Callegan to Staphylococcus aureus

Back to Details
This is a "connection" page, showing publications Michelle Callegan has written about Staphylococcus aureus.
Michelle Callegan
Connection Strength
4.014
Staphylococcus aureus
  1. Contribution of Leukocidin ED to the Pathogenesis of Staphylococcus aureus Endophthalmitis. Invest Ophthalmol Vis Sci. 2025 May 01; 66(5):11.
    View in: PubMed
    Score: 0.893
  2. The Role of CCL Chemokines in Experimental Staphylococcus aureus Endophthalmitis. Invest Ophthalmol Vis Sci. 2024 Jun 03; 65(6):12.
    View in: PubMed
    Score: 0.839
  3. An Eye on Staphylococcus aureus Toxins: Roles in Ocular Damage and Inflammation. Toxins (Basel). 2019 06 19; 11(6).
    View in: PubMed
    Score: 0.595
  4. Blood-Retinal Barrier Compromise and Endogenous Staphylococcus aureus Endophthalmitis. Invest Ophthalmol Vis Sci. 2015 Nov; 56(12):7303-11.
    View in: PubMed
    Score: 0.462
  5. Checks and balances: the ocular response to infection. Virulence. 2010 Jul-Aug; 1(4):222.
    View in: PubMed
    Score: 0.319
  6. The Role of C-X-C Chemokines in Staphylococcus aureus Endophthalmitis. Invest Ophthalmol Vis Sci. 2023 Mar 01; 64(3):10.
    View in: PubMed
    Score: 0.192
  7. Disarming Pore-Forming Toxins with Biomimetic Nanosponges in Intraocular Infections. mSphere. 2019 05 15; 4(3).
    View in: PubMed
    Score: 0.148
  8. Bloodstream-To-Eye Infections Are Facilitated by Outer Blood-Retinal Barrier Dysfunction. PLoS One. 2016; 11(5):e0154560.
    View in: PubMed
    Score: 0.120
  9. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect Immun. 1994 Jun; 62(6):2478-82.
    View in: PubMed
    Score: 0.105
  10. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones. Adv Ther. 2009 Apr; 26(4):447-54.
    View in: PubMed
    Score: 0.073
  11. Clonal associations among Staphylococcus aureus isolates from various sites of infection. Infect Immun. 2001 Jan; 69(1):345-52.
    View in: PubMed
    Score: 0.041
  12. Molecular epidemiology of Staphylococcus aureus and Enterococcus faecalis in endophthalmitis. Infect Immun. 1998 Jan; 66(1):356-60.
    View in: PubMed
    Score: 0.034
  13. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun. 1997 May; 65(5):1571-8.
    View in: PubMed
    Score: 0.032
  14. Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect Immun. 1997 Apr; 65(4):1550-6.
    View in: PubMed
    Score: 0.032
  15. Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis. Curr Eye Res. 1994 Dec; 13(12):875-8.
    View in: PubMed
    Score: 0.027
  16. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis. Invest Ophthalmol Vis Sci. 1994 Mar; 35(3):1033-7.
    View in: PubMed
    Score: 0.026
  17. Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin. Curr Eye Res. 1992 Nov; 11(11):1111-9.
    View in: PubMed
    Score: 0.023
  18. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci. 1992 Oct; 33(11):3017-23.
    View in: PubMed
    Score: 0.023
  19. Role of bacterial and host factors in infectious endophthalmitis. Chem Immunol Allergy. 2007; 92:266-275.
    View in: PubMed
    Score: 0.016
  20. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis. Jpn J Ophthalmol. 1996; 40(2):212-9.
    View in: PubMed
    Score: 0.007
  21. Bioassays for quantitating ciprofloxacin and tobramycin in aqueous humor. J Ocul Pharmacol. 1993; 9(4):311-20.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.